compounding semaglutide enforcement news On February 21, 2025, the FDA announced that semaglutide, the active ingredient in Ozempic and Wegovy, is no longer considered in shortage, signaling an improvement in national supply. As a result, New Novo Nordisk initiatives support

Effervescent formulas that already contain Vitamin C and Vitamin E offer convenience and enhanced efficacy

Retatrutide has produced notable weight-loss results in clinical trials, but it still needs broader evidence, longer safety follow-up, and local regulatory review before it can be judged like an approved treatment

Engaging consistently with your follow-up care, maintaining open communication with your healthcare team, and making gradual lifestyle adjustments will give you the best chance of a safe, successful outcome

And because this formula clearly isnt interested in doing the bare minimum when it comes to hydration, aloe rounds things out with an extra dose of soothing, skin-softening support